Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris J L M Meijer

Showing results (1-10 of 399) with videos related to

Pageof 40
Sort By:
Hematology/Oncology Clinics of North America|January 9, 2004
Primary cutaneous CD30-positive lymphoproliferative disordersRein Willemze, Chris J L M Meijer
Nature Reviews. Clinical Oncology|September 12, 2012
Screening: Cervical cancer--should we abandon cytology for screening?Chris J L M Meijer, Johannes Berkhof
Journal of Cutaneous Pathology|January 18, 2006
Classification of cutaneous T-cell lymphoma: from Alibert to WHO-EORTCRein Willemze, Chris J L M Meijer
The Lancet. Oncology|November 16, 2010
HPV-based cervical-cancer screening in ChinaMarc Arbyn, Amy Walker, Chris J L M Meijer
JAMA Oncology|June 28, 2017
Human Papillomavirus Triage of Women With Atypical Squamous Cells of Undetermined Significance-Reduction of Overtreatment NeededChris J L M Meijer, Peter J F Snijders
Nature Reviews. Clinical Oncology|April 12, 2017
Gynaecological cancer: Novel molecular subtypes of cervical cancer - potential clinical consequencesChris J L M Meijer, Renske D M Steenbergen
Nature Reviews. Clinical Oncology|January 22, 2014
Cervical cancer in 2013: Screening comes of age and treatment progress continuesChris J L M Meijer, Peter J F Snijders
JAMA Internal Medicine|June 2, 2015
Cervical cancer screening by human papillomavirus testing followed by cytology triagePaolo Giorgi-Rossi, Marc Arbyn, Chris J L M Meijer
BMJ (Clinical Research Ed.)|November 3, 2012
Follow-up after treatment for cervical intraepithelial neoplasiaMaaike C G Bleeker, Chris J L M Meijer, Johannes Berkhof
Journal of the National Cancer Institute|October 29, 2009
Re: Cost-effectiveness analysis of human papillomavirus vaccination in the NetherlandsVeerle M H Coupé, Chris J L M Meijer, Johannes Berkhof
Pageof 40

Showing results (1-10 of 399) with videos related to

Sort By:
Pageof 40
Hematology/Oncology Clinics of North America|January 9, 2004
Primary cutaneous CD30-positive lymphoproliferative disordersRein Willemze, Chris J L M Meijer
Nature Reviews. Clinical Oncology|September 12, 2012
Screening: Cervical cancer--should we abandon cytology for screening?Chris J L M Meijer, Johannes Berkhof
Journal of Cutaneous Pathology|January 18, 2006
Classification of cutaneous T-cell lymphoma: from Alibert to WHO-EORTCRein Willemze, Chris J L M Meijer
The Lancet. Oncology|November 16, 2010
HPV-based cervical-cancer screening in ChinaMarc Arbyn, Amy Walker, Chris J L M Meijer
JAMA Oncology|June 28, 2017
Human Papillomavirus Triage of Women With Atypical Squamous Cells of Undetermined Significance-Reduction of Overtreatment NeededChris J L M Meijer, Peter J F Snijders
Nature Reviews. Clinical Oncology|April 12, 2017
Gynaecological cancer: Novel molecular subtypes of cervical cancer - potential clinical consequencesChris J L M Meijer, Renske D M Steenbergen
Nature Reviews. Clinical Oncology|January 22, 2014
Cervical cancer in 2013: Screening comes of age and treatment progress continuesChris J L M Meijer, Peter J F Snijders
JAMA Internal Medicine|June 2, 2015
Cervical cancer screening by human papillomavirus testing followed by cytology triagePaolo Giorgi-Rossi, Marc Arbyn, Chris J L M Meijer
BMJ (Clinical Research Ed.)|November 3, 2012
Follow-up after treatment for cervical intraepithelial neoplasiaMaaike C G Bleeker, Chris J L M Meijer, Johannes Berkhof
Journal of the National Cancer Institute|October 29, 2009
Re: Cost-effectiveness analysis of human papillomavirus vaccination in the NetherlandsVeerle M H Coupé, Chris J L M Meijer, Johannes Berkhof
Pageof 40